Who backs Triveni Bio?
12 investors| Investor | Type |
|---|---|
| Fidelity Management & Research Company | Asset manager |
| Viking Global Investors | Asset manager |
| Alexandria Venture Investments | Other |
| OrbiMed | Growth equity |
| Goldman Sachs Asset Management | Other |
| Polaris Partners | Venture capital |
| The Invus Group | PE / buyout |
| Cormorant Asset Management | Venture capital |
| Atlas Venture | Other |
| Deep Track Capital | Venture capital |
| + 2 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Triveni Bio investors
12 investors are on record for Triveni Bio, including Fidelity Management & Research Company, Viking Global Investors, Alexandria Venture Investments and OrbiMed. By type, the record holds 5 venture capital firms, 2 asset managers and 1 private equity firm. The Series B in Jun 2025 drew 7 investors.
Free account
More of Triveni Bio with a free account
- ·The complete investor list: 12 names
- ·Watch Triveni Bio: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 12 firms already write checks for companies like Triveni Bio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View